Arbutus Biopharma (ABUS) Asset Utilization Ratio (2014 - 2026)

Arbutus Biopharma has reported Asset Utilization Ratio for 13 years, with the latest figure at 1.03 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 1900.22% year-over-year to 1.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.03 (up 1900.22% YoY) and the FY2025 annual result came in at 0.12, up 178.41% from the prior year.
• Asset Utilization Ratio advanced to 1.03 in Q1 2026 per ABUS's latest filing, from 0.15 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 1.03 in Q1 2026 and troughed at 0.04 in Q3 2024.
• A 5-year average of 0.17 and a median of 0.13 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio plunged 66.16% in 2024, then surged 1900.22% in 2026.
• Over 5 years, Asset Utilization Ratio stood at 0.2 in 2022, then tumbled by 38.75% to 0.12 in 2023, then plunged by 62.12% to 0.05 in 2024, then soared by 222.93% to 0.15 in 2025, then soared by 603.24% to 1.03 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 1.03, 0.15, and 0.15 for Q1 2026, Q4 2025, and Q3 2025 respectively.